Ullmann AJ, de Waell J, Betts R, et al. A review of the safety of micafungin compared with liposomal amphotericin B in a large phase Ⅲ trial in patients with invasive candidiasis and candidaemia[R]. Munich: 17th European Congress of Clinical Microbiology and Infectious Diseases and 25th International Congress of Chemotherapy-ECCMID/ICC, 2007.
Kuse ER, Chetchotisakd P, da Cunha CA, et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase Ⅲ randomised double blind trial[J]. Lancet, 2007, 369(9572): 1519-1527.